Columnist
Syre writes about local business, economics, and markets twice weekly in the Globe’s Boston Capital column. He joined the Globe in 1995 and previously wrote a financial column in the Boston Herald.
Latest stories
Tiny start-up lands a former Vertex CEO
By Steven Syre , Globe Staff
Alkeus Pharmaceuticals Inc. will announce today that Josh Boger, the former chief executive of Vertex Pharmaceuticals Inc., has become its executive chairman.
Globe 100 | Overview
The big comeback: The Globe 100 returns to full strength
By Steven Syre , Globe Staff
Companies large and small returned to eligibility as the markets rebounded. For the first time in three years, there are 100 of the state’s top-performing public companies in our annual ranking.
Boston Capital
Curt Schilling’s cash and credibility crisis
By Steven Syre , Globe Staff
Backed by $75 million in government loan guarantees in Rhode Island and scrambling to stay afloat, the 38 Studios computer gaming company shouldn't expect government to provide the solution.
BOSTON CAPITAL
Business guru’s tips for living
By Steven Syre , Globe Columnist
Clay Christensen, the author of business-book classic “The Innovator’s Dilemma,” is moving to the self-help aisle with familiar themes about personal choices.